Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
52
GL Quote, Financials, Valuation and Earnings
Last price:
$122.48
Seasonality move
:
4.99%
Day range:
$121.42 - $124.24
52-week range:
$71.50 - $133.76
Dividend yield:
0.8%
P/E ratio:
10.37x
P/S ratio:
2.01x
P/B ratio:
1.96x
Volume:
565.3K
Avg. volume:
701.3K
1-year change:
58.75%
Market cap:
$10.4B
Revenue:
$5.8B
EPS (TTM):
$11.95
Analysts' Opinion
-
Consensus RatingGlobe Life has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 4 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $141.18, Globe Life has an estimated upside of 13.88% from its current price of $123.97.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $111.00 representing 100% downside risk from its current price of $123.97.
Fair Value
-
According to the consensus of 8 analysts, Globe Life has 13.88% upside to fair value with a price target of $141.18 per share.
GL vs. S&P 500
-
Over the past 5 trading days, Globe Life has overperformed the S&P 500 by 0.49% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Globe Life does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Globe Life has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Globe Life reported revenues of $1.5B.
Earnings Growth
-
Globe Life has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Globe Life reported earnings per share of $3.01.
Enterprise value:
-4.3B
EV / Invested capital:
--
Price / LTM sales:
2.01x
EV / EBIT:
-2.94x
EV / Revenue:
-0.77x
PEG ratio (5yr expected):
0.56x
EV / Free cash flow:
-3.21x
Price / Operating cash flow:
8.36x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.73%
Net Income Margin (TTM):
19.33%
Return On Equity:
21.68%
Return On Invested Capital:
14.48%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $5.2B | $5.2B | $5.5B | $1.4B | $1.5B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $8.71 | $10.08 | $11.95 | $2.88 | $3.01 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $21.9B | $22B | $17.3B | $18.7B | $18.1B | |
| Total Assets | $29B | $29.8B | $26B | $28.1B | $29.1B | |
| Current Liabilities | $2.5B | $2.7B | $1.4B | $1.5B | $1.7B | |
| Total Liabilities | $20.3B | $21.1B | $22B | $23.6B | $23.8B | |
| Total Equity | $8.8B | $8.6B | $3.9B | $4.5B | $5.3B | |
| Total Debt | $1.9B | $2B | $2.1B | $2.1B | $2.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $1.5B | $1.4B | $391.4M | $336.9M | |
| Cash From Investing | -$943M | -$926.1M | -$641.5M | -$98.2M | $181.4M | |
| Cash From Financing | -$492.5M | -$541.5M | -$715.8M | -$271.7M | -$501M | |
| Free Cash Flow | $1.4B | $1.4B | $1.3B | $378.3M | $321.9M | |
GL
Sector
Market Cap
$10.4B
$603.7M
Price % of 52-Week High
92.68%
84.45%
Dividend Yield
0.8%
2.05%
Shareholder Yield
9.94%
3.98%
1-Year Price Total Return
58.75%
9.07%
Beta (5-Year)
0.606
0.555
Dividend yield:
0.8%
Annualized payout:
$0.95
Payout ratio:
7.98%
Growth streak:
9 years
Technicals
8-day SMA
Buy
Level
$122.17
200-day SMA
Buy
Level
$110.30
Bollinger Bands (100)
Buy
Level
111.32 - 126.72
Chaikin Money Flow
Buy
Level
111.7M
20-day SMA
Buy
Level
$122.04
Relative Strength Index (RSI14)
Buy
Level
51.75
ADX Line
Sell
Level
26.69
Williams %R
Sell
Level
-13.3734
50-day SMA
Sell
Level
$124.43
MACD (12, 26)
Sell
Level
-0.46
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
226.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.663)
Sell
CA Score
(Annual)
Level (-1.6655)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (5)
Buy
Ohlson Score
Level (0.1663)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
Stock Forecast FAQ
In the current month, GL has received 4 Buy ratings 4 Hold ratings, and 0 Sell ratings. The GL average analyst price target in the past 3 months is $141.18.
-
Where Will Globe Life Stock Be In 1 Year?
According to analysts, the consensus estimate is that Globe Life share price will rise to $141.18 per share over the next 12 months.
-
What Do Analysts Say About Globe Life?
Analysts are divided on their view about Globe Life share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Globe Life is a Sell and believe this share price will drop from its current level to $111.00.
-
What Is Globe Life's Price Target?
The price target for Globe Life over the next 1-year time period is forecast to be $141.18 according to 8 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is GL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Globe Life is a Leans Bullish. 4 of 8 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of GL?
You can purchase shares of Globe Life via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Globe Life shares.
-
What Is The Globe Life Share Price Today?
Globe Life was last trading at $122.48 per share. This represents the most recent stock quote for Globe Life. Yesterday, Globe Life closed at $123.97 per share.
-
How To Buy Globe Life Stock Online?
In order to purchase Globe Life stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 6.05% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 2.03% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 4.31% over the past day.
